person

Norbert C.

Country
Hungary
Department
Ophtalmology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
108
Sites with multiple studies

Has run more than one trial at 108 of 224 partner sites.

Specializations

Retinal Disorders

The investigator specializes in treating various retinal conditions, particularly focusing on diabetic eye complications. Their research encompasses both diabetic macular edema (DME) and diabetic retinopathy, exploring innovative therapeutic approaches for these vision-threatening conditions.

  • Diabetic Macular Edema Management
  • Diabetic Retinopathy Treatment
  • Visual Acuity Improvement Strategies

Their work involves evaluating novel eye drop formulations and therapeutic compounds for diabetic eye disease management.

Vascular Eye Disease

The investigator has significant expertise in treating macular edema secondary to retinal vein occlusion. Their research includes investigating advanced therapeutic options, including higher-concentration medications for improved treatment outcomes.

  • Retinal Vein Occlusion Treatment
  • Anti-VEGF Therapy Optimization
  • Extended-interval Dosing Protocols

Their work focuses on developing treatment regimens that maintain efficacy while reducing treatment burden on patients.

Eyelid Disorders

The investigator conducts research in the treatment of acquired blepharoptosis, exploring new pharmacological interventions. Their work includes evaluating novel topical treatments for this condition affecting upper eyelid position.

  • Blepharoptosis Management
  • Topical Treatment Development
  • Non-surgical Therapeutic Options

Their research aims to establish effective non-surgical alternatives for patients with eyelid disorders.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.